HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Initiates Discussions on Palliative Care for CV Diseases
June 1, 2016
-
REGULATORY Lawmakers Eye Genomic Medicine Bill to Fuel Diagnostics Development
May 31, 2016
-
REGULATORY AZ’s Ticagrelor, Boehringer’s Triple Combo Fail to Clear MHLW Advisory Panel
May 30, 2016
-
ORGANIZATION Sumitomo Dainippon Pres. Tada Picked as New Chief of FPMAJ
May 27, 2016
-
REGULATORY MHLW to Request Budgets to Promote Venture Companies in Response to Growth Strategy
May 26, 2016
-
REGULATORY MHLW to Begin Discussions this Fiscal Year on Regulation of Plasma Exports
May 25, 2016
-
BUSINESS Japan’s Top 3 Drug Makers Join Forces on Biomarker Research
May 24, 2016
-
BUSINESS Generic Makers Enjoy Revenue Rises as Govt Tailwinds Continue: Jiho Tally
May 23, 2016
-
REGULATORY Clinical Research Bill to Make It Easier for Companies to Provide Unapproved Drugs for Clinical Programs: LDP Lawmaker
May 20, 2016
-
REGULATORY Pricy Meds Again a Hot Topic at Chuikyo, MHLW Set to Launch Concrete Discussions
May 19, 2016
-
REGULATORY Chuikyo OKs 16 APIs for Listing on May 25, Novartis’s Melanoma Combo Gets 45% Price Premium
May 18, 2016
-
BUSINESS Top 8 Japan Drug Makers Relish 2.6-Fold Operating Profit Jump on Global Brands
May 17, 2016
-
BUSINESS As Tagrisso Launch Nears, AZ Pushes Stringent Prerequisites for Facilities, Doctors to Ensure Safety
May 17, 2016
-
ACADEMIA MHLW Study Group Drafting Guidelines for Assessing Cost-Effectiveness of Vaccines Proposed for Inclusion in Public Vaccination Programs
May 16, 2016
-
BUSINESS Daiichi Sankyo Sees 7.3% Sales Rise, but Girding for FY2016 Dip on Olmesartan Cliff
May 13, 2016
-
BUSINESS Ono Delivers Record Sales on Buoyant Opdivo, FY2016 Outlook Tops 250 Billion Yen
May 12, 2016
-
BUSINESS AZ Set to Double Japan Sales by 2020 on Cancer Meds, No Patent Cliff in Sight: Local Pres. Baertschi
May 11, 2016
-
REGULATORY Pharmacists Can Make Big Contribution to Health Finances by Reducing Drug Waste: MHLW Study Group Chief
May 10, 2016
-
ACADEMIA Use Patient Registries for Orphan, Intractable Diseases First: MHLW Study Group Chief
May 9, 2016
-
BUSINESS Sales Rep Survey - Part 2: Drug Makers Exploring Viable Roles amid Govt’s Community-Based Care Initiative
May 6, 2016
ページ
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
In a recent conversation with James Feliciano, former president of AbbVie Japan, we delved into the intricacies of leadership in the Japanese pharmaceutical industry. Feliciano, a seasoned industry veteran, shared valuable insights into his experiences, challenges, and successes.Navigating the Abbott…